These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15183956)

  • 1. Expression of cathepsins B, H, and L and their inhibitors as markers of transitional cell carcinoma of the bladder.
    Staack A; Tolic D; Kristiansen G; Schnorr D; Loening SA; Jung K
    Urology; 2004 Jun; 63(6):1089-94. PubMed ID: 15183956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder.
    Staack A; Koenig F; Daniltchenko D; Hauptmann S; Loening SA; Schnorr D; Jung K
    Urology; 2002 Feb; 59(2):308-12. PubMed ID: 11834417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
    Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
    Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
    Kawasaki G; Kato Y; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
    Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
    Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
    Werle B; Ebert W; Klein W; Spiess E
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsins B and L are markers for clinically invasive types of meningiomas.
    Strojnik T; Zidanik B; Kos J; Lah TT
    Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.
    Falgueyret JP; Black WC; Cromlish W; Desmarais S; Lamontagne S; Mellon C; Riendeau D; Rodan S; Tawa P; Wesolowski G; Bass KE; Venkatraman S; Percival MD
    Anal Biochem; 2004 Dec; 335(2):218-27. PubMed ID: 15556560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
    Svatek RS; Karam J; Karakiewicz PI; Gallina A; Casella R; Roehrborn CG; Shariat SF
    J Urol; 2008 Feb; 179(2):478-84; discussion 484. PubMed ID: 18076936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
    Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
    Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cathepsins B, H, L and kininogen in breast cancer patients.
    Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna J; Turk V
    Agents Actions Suppl; 1992; 38 ( Pt 2)():350-7. PubMed ID: 1334335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins B, H and L in human breast carcinoma.
    Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna M; Dolenc I; Popovic T; Cotic V; Turk V
    Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):69-74. PubMed ID: 1316176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
    Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
    Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
    Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J
    J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia.
    Visscher DW; Sloane BF; Sameni M; Babiarz JW; Jacobson J; Crissman JD
    Mod Pathol; 1994 Jan; 7(1):76-81. PubMed ID: 8159656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease.
    Shuja S; Murnane MJ
    Int J Cancer; 1996 May; 66(4):420-6. PubMed ID: 8635854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
    Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
    Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of human bladder tumor invasion: role of protease cathepsin B.
    Weiss RE; Liu BC; Ahlering T; Dubeau L; Droller MJ
    J Urol; 1990 Sep; 144(3):798-804. PubMed ID: 2201799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.